Authors outline the efficacy and safety of topical NSAIDs for the treatment of acute and chronic musculoskeletal pain conditions including osteoarthritis.
Data for this study were sourced from 4 active treatment arms of 4 randomized, controlled trials conducted by the National Institutes of Health in the United States between 2006 and 2018.
Researchers developed and validated a diagnostic prediction model to distinguish between juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome.
The growth in the number of clinicians with waivers to prescribe buprenorphine slowed during the pandemic, and support and mentorship are needed to facilitate obtaining a waiver.